Product Information
SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $4.9797 per EA under NDC 43598061860. Its NADAC has been published 118 times since May 22, 2024.
FDA first approved this application on Aug 9, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1000; 2.5 mg/1; mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598061860
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METFORMIN HYDROCHLORIDE; SAXAGLIPTINApproval Type
Generic (ANDA)
FDA Application
ANDA207678FDA Approved
8/9/2023
TE Code
AB
On Market Since
8/9/2023
Pharmacological Classes
Price Statistics
The NADAC for SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET has been published 118 times since May 22, 2024, and over the history we have for it it has risen 6.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9797 per EA |
|---|---|
| All-time high | $5.1601 (Nov 12, 2025) |
| All-time low | $4.1869 (Sep 18, 2024) |
| 52-week high | $5.1601 |
| 52-week low | $4.5490 |
| Median price | $4.6574 |
| Average price | $4.6700 |
| Largest weekly change | +12.3% (Oct 23, 2024) |
| Weeks tracked | 118 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Saxagliptin and Metformin Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $4.9797 per EA (NDC 43598061860), effective Aug 19, 2026.
How has the price of SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET has risen 6.4%. It has been tracked across 118 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET?
Since May 22, 2024, the NADAC for SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET has ranged from a low of $4.1869 (Sep 18, 2024) to a high of $5.1601 (Nov 12, 2025), with a median of $4.6574 per EA.
Are there cheaper alternatives to SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET?
SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET (NDC 43598061860) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.